EUVIMEDEUVIMED entdecken
Crossref

Enantioselective Total Syntheses of Vallesamidine and Schizozygane Alkaloids

Gujjula V Ramakrishna, Zurwa Latif, Filippo Romiti iD

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.4c16900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Gujjula V Ramakrishna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, Texas 75080, United States. Hauptthemen laut MEDLINE: Alkaloids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Welch Foundation, Cancer Prevention and Research Institute of Texas, University of Texas at Dallas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaloidsStereoisomerismMolecular StructureCatalysis

Substanzen

Alkaloids

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, Texas 75080, United States.

ORCID-Profile: Filippo Romiti

Förderung

  • Welch Foundation
  • Cancer Prevention and Research Institute of Texas
  • University of Texas at Dallas

Zitieren

APA

Ramakrishna, G. V., Latif, Z., & Romiti, F. (2025). Enantioselective Total Syntheses of Vallesamidine and Schizozygane Alkaloids. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c16900

Vancouver

Ramakrishna GV, Latif Z, Romiti F. Enantioselective Total Syntheses of Vallesamidine and Schizozygane Alkaloids. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c16900

BibTeX
@article{Ramakrishna2025,
  author = {Ramakrishna, Gujjula V and Latif, Zurwa and Romiti, Filippo},
  title = {Enantioselective Total Syntheses of Vallesamidine and Schizozygane Alkaloids},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.4c16900}
}
Kostenlos starten →